Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 61

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 61
---
 such annual meeting is held solely as a virtual meeting, absent disability, illness, an emergency, or other unusual circumstances reasonably necessitating the director not being at the annual meeting. All of our directors serving on the Board at the time attended our virtual 2024 annual meeting of stockholders.

Committees of the Board

During 2024, the Board had four standing committees: the audit committee, the compensation committee, the nominating and corporate governance committee and the research and development committee. The charters for the audit committee, the compensation committee and the nominating and corporate governance committee, as adopted by the Board, are available on our website atwww.sarepta.comunder “Investors — Corporate Governance.” The functions performed by each committee are described below.

<div align='center'>37</div>

The following table summarizes the composition of our committees as of April 24, 2025:

|                            | Audit Committee | Compensation 
 Committee    | Nominating and 
 Corporate      
 Governance     
 Committee      | Research and 
 Development  
 Committee    |
| Richard J. Barry           | *               | **           | **             |              |
| M. Kathleen Behrens, Ph.D. | **              |              |                | *            |
| Kathryn J. Boor, Ph.D.     |                 | *            | *              |              |
| Michael Chambers           |                 |              |                | *            |
| Deirdre Connelly           |                 | *            | *              |              |
| Douglas S. Ingram          |                 |              |                |              |
| Stephen L. Mayo, Ph.D.     | *               |              |                | *            |
| Claude Nicaise, M.D.       |                 | *            |                | *            |
| Hans Wigzell, M.D., Ph.D.  |                 |              | *              | **           |

*Represents membership on a committee **Represents Chair of a committee Audit Co mmittee The audit committee reviews with our independent registered public accounting firm the scope, results and costs of the annual audit and our accounting policies and financial reporting. Our audit committee (i) has direct responsibility for the appointment, compensation, retention and oversight of our independent registered public accounting firm, (ii) discusses with our auditors their independence from management, (iii) reviews the scope of the independent annual audit, (iv) establishes procedures for handling complaints regarding our accounting practices, (v) oversees risks including those related to cybersecurity and climate and (vi